(MedPage Today) — CHICAGO — An investigational, oral small-molecule GLP-1 receptor agonist improved glycated hemoglobin levels in adults with early-stage type 2 diabetes, a phase III randomized trial found.
Among 559 participants in ACHIEVE…
Source link : https://www.medpagetoday.com/meetingcoverage/ada/116186
Author :
Publish date : 2025-06-21 21:36:00
Copyright for syndicated content belongs to the linked Source.
